Research is still evolving
Early assessment can be helpful in understanding available care options
PDC is calculated as (number of days covered) / (total days in the time period) Cohorts and Time Horizons The second phase of analysis extends and refines the original analysis by separating cohorts by primary indication: Diabetes cohort: Individuals with a diabetes indication and GLP-1 use primarily for glycemic control Weight loss cohort: Individuals using GLP-1s for obesity or weight management without a diabetes indication Extending observation periods 30-month analysis window for the diabetes cohort 18-month analysis window for the weight loss cohort This approach allows us to evaluate whether the cost and clinical trends seen in the first white paper persist over a longer timeframe and whether they hold consistently across key sub populations
How the Menstrual Cycle Affects GLP-1 Response The menstrual cycle creates a predictable pattern of metabolic shifts that influence how women experience GLP-1 therapy
As lens cells age, they move towards the nucleus and their GSH levels fall (Cvekl & Ashery-Padan, 2014), which may explain why the older cells in the lens nucleus are more prone to developing cataracts The current standard treatment for cataracts is surgery, which replaces the cloudy lens with a clear artificial lens
Manufacturers are taking notice of this , and taking action to get a piece of the demand
